甲状腺影像引导消融术的演进:历史综述
该历史综述通过系统检索PubMed并预设筛选标准,纳入43篇里程碑论文,将甲状腺影像引导消融的发展分为五个阶段(1985-2025),涵盖从经皮乙醇注射到激光、射频、微波及高强度聚焦超声等技术。近10年随访研究证实微创治疗对良性结节持久有效,对低风险甲状腺微小乳头状癌持续肿瘤控制。影像引导甲状腺消融已从实验创新转变为基于证据、指南支持的精准医学治疗领域。
要点
- 甲状腺消融技术历经概念起源、热消融时代、方法标准化、肿瘤学巩固和指南认可五个阶段。
- 近10年随访证实微创治疗对良性结节疗效持久,对低风险微小乳头状癌肿瘤控制持续。
- 影像引导消融已成为指南支持的精准、保器官、微创内分泌肿瘤学治疗手段。
局限性
- 本文为历史综述,采用定性分析而非系统评价或荟萃分析,未提供定量合并数据。
- 仅纳入43篇里程碑论文,可能存在选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Over the past four decades, the management of thyroid nodules and selected thyroid malignancies has progressively shifted from surgery-centered approaches toward image-guided minimally invasive treatments (MITT). What began in 1985 with ultrasound-guided percutaneous ethanol injection evolved into a range of energy-based techniques, including laser ablation (LA), radiofrequency ablation (RFA), microwave ablation (MWA), and high-intensity focused ultrasound (HIFU).This historical review aimed to reconstruct the major milestones in the development of image-guided thyroid ablation. A systematic PubMed literature search and predefined selection criteria were used to identify seminal studies, first clinical applications, major technological innovations, comparative studies, guideline-defining publications, and landmark long-term follow-up studies. Overall, 43 milestone papers were included for qualitative historical analysis. The evolution of thyroid ablation can be divided into five phases: conceptual origins (1985-1999), birth of the thermal procedures' era (2000-2006), methodological standardization (2007-2012), oncologic consolidation and comparative evidence (2013-2018), and final codification by means of international guideline endorsement and long-term validation (2019-2025). Recent 10-year follow-up studies have confirmed the durable efficacy of MITT for benign nodule management and their sustained oncologic control in low-risk papillary thyroid microcarcinoma. Image-guided thyroid ablation has transitioned from experimental innovation to an evidence-based, guideline-supported therapeutic domain, representing a paradigm shift toward precision medicine, organ preservation, and minimally invasive endocrine oncology.
引用
- Mauri G, Rossi E, Papini E, et al. The evolution of image-guided ablations for thyroid disorders: a historical review. Radiol Med. 2026. PMID: 42911528. doi:10.1007/s11547-026-02296-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。